LIFEMD, INC. (LFMD) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$7.13M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$8.93M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$1.97M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$2.35M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | -$7.13M | (m) | $47.28M | (m) | $67.83K* | -$6.93M* | (m) | (m) | (m) | (m) |
| 2026-03-31 | Reported | (m) | -$8.93M | (m) | $50.16M | (m) | $105.18K | $444.62K | (m) | (m) | (m) | (m) |
| 2025-09-30 | Reported | (m) | -$1.97M | (m) | $60.17M | (m) | $821.00K* | -$147.14K* | (m) | (m) | (m) | $169.13K |
| 2025-06-30 | Reported | (m) | -$2.35M | (m) | $49.02M | (m) | $776.67K* | $8.64M* | (m) | (m) | (m) | (m) |
| 2025-03-31 | Reported | (m) | -$1.18M | (m) | $50.89M | (m) | $117.55K | $3.07M | (m) | (m) | (m) | (m) |
| 2024-09-30 | Reported | (m) | -$4.00M | (m) | $53.27M | (m) | $447.80K* | $6.70M* | (m) | (m) | (m) | $232.52K |
| 2024-06-30 | Reported | (m) | -$6.31M | (m) | $50.66M | (m) | $642.05K* | $4.54M* | (m) | (m) | (m) | (m) |
| 2024-03-31 | Reported | (m) | -$6.17M | (m) | $44.14M | (m) | $175.59K | $5.20M | (m) | (m) | (m) | (m) |
| 2023-09-30 | Reported | (m) | -$4.57M | (m) | $38.61M | (m) | $30.26K* | $1.08M* | (m) | (m) | (m) | (m) |
| 2023-06-30 | Reported | (m) | -$4.90M | (m) | $35.95M | (m) | $30.56K* | $4.64M* | (m) | (m) | (m) | (m) |
| 2023-03-31 | Reported | (m) | -$2.85M | (m) | $33.13M | (m) | $33.66K | -$2.61M | (m) | (m) | (m) | (m) |
| 2022-09-30 | Reported | (m) | -$7.07M | (m) | $31.41M | (m) | $21.55K* | -$2.78M* | (m) | (m) | (m) | (m) |
| 2022-06-30 | Reported | (m) | -$12.90M | (m) | $30.46M | (m) | $90.18K* | -$10.10M* | (m) | (m) | (m) | (m) |
| 2022-03-31 | Reported | (m) | -$13.11M | (m) | $29.04M | (m) | $267.15K | -$8.09M | (m) | (m) | (m) | (m) |
| 2021-09-30 | Reported | (m) | -$12.59M | (m) | $24.95M | (m) | $51.99K* | -$7.42M* | (m) | (m) | (m) | (m) |
| 2021-06-30 | Reported | (m) | -$16.13M | (m) | $22.31M | (m) | (m) | -$10.73M* | (m) | (m) | (m) | (m) |
| 2021-03-31 | Reported | (m) | -$11.92M | (m) | $18.20M | (m) | (m) | -$9.11M | (m) | (m) | (m) | (m) |
| 2020-09-30 | Reported | (m) | -$20.53M | (m) | $11.01M | (m) | (m) | -$4.50M* | (m) | (m) | (m) | (m) |
| 2020-06-30 | Reported | (m) | -$3.22M | (m) | $9.09M | (m) | (m) | -$1.76M* | (m) | (m) | (m) | (m) |
| 2020-03-31 | Reported | (m) | -$1.74M | (m) | $4.30M | (m) | (m) | $661.36K | (m) | (m) | (m) | (m) |
| 2019-09-30 | Reported | (m) | -$973.71K | (m) | $3.13M | (m) | (m) | -$547.69K* | (m) | (m) | (m) | (m) |
| 2019-06-30 | Reported | (m) | -$833.16K | (m) | $2.70M | (m) | (m) | $93.72K* | (m) | (m) | (m) | (m) |
| 2019-03-31 | Reported | (m) | -$563.37K | (m) | $2.70M | (m) | (m) | $546.46K | (m) | (m) | (m) | (m) |
| 2018-09-30 | Reported | (m) | -$385.63K | (m) | (m) | (m) | (m) | -$250.55K* | (m) | (m) | (m) | (m) |
| 2018-06-30 | Reported | (m) | -$938.45K | (m) | (m) | (m) | (m) | -$304.58K* | (m) | (m) | (m) | (m) |
| 2018-03-31 | Reported | (m) | -$279.31K | (m) | (m) | (m) | (m) | $65.93K | (m) | (m) | (m) | (m) |
| 2017-09-30 | Reported | (m) | -$273.57K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | Reported | (m) | -$380.30K | (m) | (m) | (m) | (m) | -$39.31K* | (m) | (m) | (m) | (m) |
| 2017-03-31 | Reported | (m) | -$401.79K | (m) | (m) | (m) | (m) | -$473.26K | (m) | (m) | (m) | (m) |
| 2016-09-30 | Reported | (m) | -$207.70K | (m) | (m) | (m) | (m) | -$35.04K* | (m) | (m) | (m) | (m) |
| 2016-06-30 | Reported | (m) | -$153.63K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | Reported | (m) | -$153.63K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | Reported | (m) | -$105.10K | (m) | (m) | (m) | (m) | -$122.16K | (m) | (m) | (m) | (m) |
| 2015-09-30 | Reported | (m) | $17.94K | (m) | (m) | (m) | (m) | -$23.88K* | (m) | (m) | (m) | (m) |
| 2015-06-30 | Reported | (m) | -$17.17K | (m) | (m) | (m) | (m) | $13.75K* | (m) | (m) | (m) | (m) |
| 2015-03-31 | Reported | (m) | $7.83K | (m) | (m) | (m) | (m) | -$70.19K | (m) | (m) | (m) | (m) |
| 2014-09-30 | Reported | (m) | -$132.94K | (m) | (m) | (m) | (m) | -$15.14K* | (m) | (m) | (m) | (m) |
| 2014-06-30 | Reported | (m) | -$75.38K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | Reported | (m) | -$75.38K | (m) | (m) | (m) | (m) | $29.74K* | (m) | (m) | (m) | (m) |
| 2014-03-31 | Reported | (m) | -$177.64K | (m) | (m) | (m) | (m) | -$6.65K | (m) | (m) | (m) | (m) |
| 2013-09-30 | Reported | (m) | -$168.67K | (m) | (m) | (m) | (m) | -$74.61K* | (m) | (m) | (m) | (m) |
| 2013-06-30 | Reported | (m) | -$20.15K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | Reported | (m) | -$20.15K | (m) | (m) | (m) | (m) | $22.14K* | (m) | (m) | (m) | (m) |
| 2013-03-31 | Reported | (m) | -$70.79K | (m) | (m) | (m) | (m) | -$60.01K | (m) | (m) | (m) | (m) |
| 2012-09-30 | Reported | (m) | -$163.64K | (m) | (m) | (m) | (m) | -$86.69K* | (m) | (m) | (m) | (m) |
| 2012-06-30 | Reported | (m) | -$215.70K | (m) | (m) | (m) | (m) | -$79.16K* | (m) | (m) | (m) | (m) |
| 2012-03-31 | Reported | (m) | -$35.83K | (m) | (m) | (m) | (m) | $377.00 | (m) | (m) | (m) | (m) |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | -$7.67M | (m) | $194.06M | (m) | $1.87M | $8.28M | (m) | (m) | (m) | $45.72K |
| 2024-12-31 | Reported | (m) | -$20.40M | (m) | $154.82M | (m) | $1.46M | $17.51M | (m) | (m) | (m) | $598.00K |
| 2023-12-31 | Reported | (m) | -$14.49M | (m) | $152.55M | (m) | $203.81K | $8.82M | (m) | (m) | (m) | $428.00K |
| 2022-12-31 | Reported | (m) | -$43.45M | (m) | $119.03M | (m) | $366.63K | -$22.94M | (m) | (m) | (m) | $360.70K |
| 2021-12-31 | Reported | (m) | -$54.30M | (m) | $92.88M | (m) | $247.37K | -$33.09M | (m) | (m) | (m) | $7.70K |
| 2020-12-31 | Reported | (m) | -$57.82M | (m) | $37.29M | (m) | (m) | -$12.13M | (m) | (m) | (m) | $122.50K |
| 2019-12-31 | Reported | (m) | -$2.89M | (m) | $12.47M | (m) | (m) | $251.41K | (m) | (m) | (m) | -$122.50K |
| 2018-12-31 | Reported | (m) | -$2.06M | (m) | $42.52K | (m) | (m) | -$905.52K | (m) | (m) | (m) | -$124.70K |
| 2017-12-31 | Reported | (m) | -$1.23M | (m) | (m) | (m) | (m) | -$817.22K | (m) | (m) | (m) | (m) |
| 2016-12-31 | Reported | (m) | -$1.17M | (m) | (m) | (m) | (m) | -$407.91K | (m) | (m) | (m) | (m) |
| 2015-12-31 | Reported | (m) | -$262.22K | (m) | (m) | (m) | (m) | -$295.12K | (m) | $23.93K | (m) | (m) |
| 2014-12-31 | Reported | (m) | -$530.88K | (m) | (m) | (m) | (m) | $33.44K | (m) | (m) | (m) | (m) |
| 2013-12-31 | Reported | (m) | -$546.41K | (m) | (m) | (m) | (m) | -$259.07K | (m) | (m) | (m) | (m) |
| 2012-12-31 | Reported | (m) | -$540.02K | (m) | (m) | (m) | (m) | -$229.73K | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |